Skip to main content
Caplight Logo









AIM7

AIM7

Private
Houston, TexasHealthcare & Life Scienceshttps://www.aim7.com/

Last Round

Seed

Dec 19, 2022

Total Funding Raised

$1.3M

Company Overview

AIM7 is a health and wellness technology company that provides an AI-powered data integration platform for personalized fitness, recovery, and performance recommendations.

Sector

Healthcare & Life Sciences

Verticals

Sports & Fitness, Healthcare Analytics, Health IoT, Personalization

Business Model

B2C

Customer Profile

Subscription SaaS

AI Layer

Application

Keywords

fitness appwearable datarecovery trackingAI fitness coachbiometric analysisperformance optimizationbiohackingtraining insightsSaaSAPIreadiness scoredigital healthhealth IoTquantified selfpersonalized training

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

AIM7 Comparables

Compare AIM7 with similar companies based on industry and business-model similarity.

AIM7 comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Athlytic
88%
Vora AI Inc.
87%
Bevel
86%

AIM7 Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
SeedDec 19, 2022

Key People

Founding team and executive leadership

Erik Korem

Founder CEO at AIM7

Founding Team

Market signals

Structured signals derived from secondary market and firmographic data.

  • Apr 23, 2026

    Monthly visitors increased 48% MoM.

  • Mar 3, 2026

    Monthly visitors increased 35% MoM.

AIM7 Filings

Explore SEC and related filing metadata, where available.

AIM7 filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Request access

Frequently Asked Questions

Common questions about AIM7's valuation, stock price, and market status.

Is AIM7 a public or private company?

AIM7 is a private company.

What is the current stock price of AIM7?

AIM7 is a private company with no public stock price. No recent secondary market data is available.

How much is AIM7 worth (valuation)?

Valuation information for AIM7 is not publicly available.

Can I buy AIM7 stock?

AIM7 shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.

When was AIM7's last funding round?

AIM7's most recent funding round was Seed on December 19, 2022.

Who are the main investors in AIM7?

Investor information for AIM7 is not publicly disclosed.

Will AIM7 IPO soon?

No public IPO plans have been announced for AIM7.

How can I track AIM7 secondary market activity?

Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor AIM7's secondary market activity and sign up for updates.

Firmographic Details

HeadquartersHouston, Texas
Employee Range11
Year Founded2020
Last FundingDec 19, 2022

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?